One‐year clinical outcomes of anticoagulation therapy among Japanese patients with atrial fibrillation: The Hyogo AF Network (HAF‐NET) Registry

Figures

• 

  Figure 1. Registration card. The left panel shows the front side of the registration card where the actual anticoagulation therapy could be checked. The following text was described in the registration card: “Please inform your primary care doctor of the following events: Ischemic stroke, SE, Hemorrhagic stroke, new onset dementia, hospitalization for major bleeding, hospitalization for cardiac event, all‐cause mortality” was written by Japanese. The right panel shows the opposite side of the registration card where the patient name and birthday, primary care doctor's name and telephone number were written. The following text was described in the registration card: “Please always carry this card to inform your doctors of anticoagulation therapy. When you see a doctor, please show this card your doctors, dentists and pharmacists. According to the doctor's suggestion, please do not change the dosage of anticoagulants by self‐determination. Please inform your primary care doctor when the anticoagulation therapy reluctantly stopped.”

• 

  Figure 2. The distribution of the CHADS2 and CHA2DS2‐VASc scores. Panel A shows the CAHDS2 score distribution and panel B the CHA2DS2‐VASc score distribution

• 

  Figure 3. The proportion of anticoagulants and dosing. Panel A shows the proportion of anticoagulants and panel B the proportion of standard or low dosing of each DOAC. The numbers indicated the percentages

• 

  Figure 4. Kaplan‐Meier curve for the primary and secondary endpoints, ischemic strokes/SEs, major bleeding, new onset dementia, cardiac events, and all‐cause mortality between the warfarin and DOAC users. The clinical events were assessed among 667 age, BW, CHADS2 score, and CHA2DS2‐VASc score‐matched DOAC and warfarin users